Trailing-twelve-month (TTM) revenue is $9.97 Billion with a year-over-year growth of +2.56%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-11-30 | $2,552,925,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-28 |
| Q1 FY2026Period ended 2026-02-28 | $2,500,391,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-03 |
| Q2 FY2026Period ended 2026-05-31 | $2,462,473,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-02 |
| Q3 FY2026Period ended 2026-08-31 | $2,453,679,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-29 |
| TTM revenue | $9,969,468,000 |
Current P/S: $1,548,034,271 market capitalization ÷ $9,969,468,000 TTM revenue = 0.16x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T13:45:13.000Z. Latest revenue period ended 2026-08-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-08-31): $2.45B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:46:12.440Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-11-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-11-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-11-30 · USD | FY20222022-11-30 · USD | FY20232023-11-30 · USD | FY20242024-11-30 · USD | FY20252025-11-30 · USD |
|---|---|---|---|---|---|
| Banking, Financial Services and Insurance | $862M | $968M | $1.1B | $1.5B | N/A |
| Communications and Media | $1.0B | $1.1B | $1.1B | $1.5B | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-11-30 · USD | FY20222022-11-30 · USD | FY20232023-11-30 · USD | FY20242024-11-30 · USD | FY20252025-11-30 · USD |
|---|---|---|---|---|---|
| CANADA | $338M | $326M | $317M | $308M | $302M |
| GERMANY | N/A | $232M | $233M | $388M | $334M |
| INDIA |
$9.97B
$9.97 Billion
+2.56%
vs. $9.72B a year ago (TTM)
+12.96%
5 Year compound annual growth rate
1 Year
+2.56%
3 Year
+15.17%
5 Year
+12.96%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $9.83B | +$206.87M | +2.15% |
| 2024 | $9.62B | +$2.50B | +35.20% |
| 2023 | $7.11B | +$790.23M | +12.49% |
| 2022 | $6.32B | +$737.46M | +13.20% |
| 2021 | $5.59B | +$867.48M | +18.38% |
| 2020 |
TTM Growth
+2.56%
3-Year CAGR
+15.17%
5-Year CAGR
+12.96%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 27 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T13:46:12.440Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| Healthcare |
|---|
| $490M |
| $608M |
| $696M |
| $727M |
| N/A |
| Other Industries | $485M | $507M | $554M | $872M | N/A |
|---|
| Reportable Segment | N/A | N/A | N/A | N/A | $9.8B |
|---|
| $811M |
| $898M |
| $1.1B |
| $1.1B |
| OTHERS | $2.0B | $1.9B | $2.6B | $4.8B | $5.1B |
|---|
| PHILIPPINES | $1.3B | $1.5B | $1.6B | $1.6B | $1.6B |
|---|
| UNITED STATES | $885M | $1.4B | $1.3B | $1.1B | $1.1B |
|---|
| $4.72B |
| +$11.62M |
| +0.25% |
| 2019 | $4.71B | +$2.24B | +91.13% |
| 2018 | $2.46B | +$472.97M | +23.77% |
